Paris, France and Camberley, UK – 3 May 2019 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT) an international specialist in clinical diagnostics, announces that, pursuant to the Convertible Bonds with Warrants Funding Programme (“Agreement”) announced on 23 April 2019, it has issued two tranches of new ordinary shares of €1/15 each (“Ordinary Shares”) to Negma
Visit PageCategory: Products
Conversion d’emprunts obligataires
Paris, France et Camberley, UK – 3 mai 2019 – Novacyt (EURONEXT GROWTH : ALNOV ; AIM : NCYT) annonce qu’en vertu du programme de financement par des Obligations Convertibles assorties de warrants (« l’Accord ») annoncé le 23 avril 2019, elle a émis deux tranches d’actions ordinaires nouvelles de 1/15ème d’euro chacune (« Actions
Visit PageChange of Adviser and Update on Directors’ Disclosures
Paris, France and Camberley, UK – 3 May 2019 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, is pleased to announce the appointment of SP Angel Corporate Finance LLP as its Nominated Adviser and joint broker with immediate effect. http://novacyt.com/wp-content/uploads/2019/05/Novacyt-Change-of-Adviser-03.05.19.pdf
Visit Page